EASY BIOInc
EASY BIO,Inc. provides specialized piglet feed and feed additives solutions in South Korea and internationally. The company was founded in 2020 and is based in Seoul, South Korea.
EASY BIOInc (353810) - Total Liabilities
Latest total liabilities as of September 2025: ₩225.48 Billion KRW
Based on the latest financial reports, EASY BIOInc (353810) has total liabilities worth ₩225.48 Billion KRW as of September 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
EASY BIOInc - Total Liabilities Trend (2020–2024)
This chart illustrates how EASY BIOInc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
EASY BIOInc Competitors by Total Liabilities
The table below lists competitors of EASY BIOInc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SG Finserve Limited
NSE:SGFIN
|
India | ₹19.18 Billion |
|
Decora SA
WAR:DCR
|
Poland | zł167.90 Million |
|
CPI Card Group Inc
NASDAQ:PMTS
|
USA | $432.72 Million |
|
Consorcio ARA S. A. B. de C. V.
OTCGREY:CNRFF
|
USA | $9.08 Billion |
|
Dufu Tech Corp Bhd
KLSE:7233
|
Malaysia | RM98.68 Million |
|
CVWLF
PINK:CVWLF
|
USA | $717.27 Million |
|
Danang Rubber JSC
VN:DRC
|
Vietnam | ₫2.23 Trillion |
|
All For One Steeb AG
F:A1OS
|
Germany | €215.29 Million |
Liability Composition Analysis (2020–2024)
This chart breaks down EASY BIOInc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.48 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 2.38 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.69 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how EASY BIOInc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for EASY BIOInc (2020–2024)
The table below shows the annual total liabilities of EASY BIOInc from 2020 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | ₩271.21 Billion | +156.18% |
| 2023-12-31 | ₩105.87 Billion | -1.83% |
| 2022-12-31 | ₩107.85 Billion | +44.23% |
| 2021-12-31 | ₩74.78 Billion | +34.05% |
| 2020-12-31 | ₩55.78 Billion | -- |